Auckland Cancer Society Research Centre

Funding bodies for the ACSRC

Cancer Society Auckland Northland provides core funding for the ACSRC's work. This funding is supplemented by competitive research grants from a wide variety of agencies, including:

Commercial contracts with a number of companies also provide significant support, with current or completed contracts from Seattle Genetics (US), Xenova (UK), Cancer Research Campaign Technology (UK), Pfizer (US), Genentech (US), Antisoma (UK), Supergen (US), Cerus Corp (US), Convert Pharmaceuticals (Belgium), Novartis (US), Onyx (US) and Rain Therapeutics (US).

The ACSRC has also generated start-up companies through Auckland UniServices: KEA Therapeutics, Pathway Therapeutics, Proacta Inc. These have also supported research in the Centre.